RE:RE:Drinking the wrong Koolaid with Phase 1Took the offer and looked it up, Heres why Biogen lost 20 billion in market value in July 2015. "The primary culprits were weaker-than-expected- second quarter earning results and early stage data involving Alzheimers drug aducaumab that didn't exactly thrill investors".